HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramasamy Paulmurugan Selected Research

Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

9/2008Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
2/2008US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramasamy Paulmurugan Research Topics

Disease

77Neoplasms (Cancer)
10/2023 - 07/2003
14Breast Neoplasms (Breast Cancer)
05/2023 - 04/2011
12Triple Negative Breast Neoplasms
04/2023 - 01/2014
12Glioblastoma (Glioblastoma Multiforme)
01/2023 - 12/2015
9Hepatocellular Carcinoma (Hepatoma)
08/2023 - 05/2012
6Neoplasm Metastasis (Metastasis)
04/2023 - 03/2015
4Hypoxia (Hypoxemia)
12/2011 - 05/2008
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2021
3Adenocarcinoma
11/2021 - 11/2020
2Colitis
01/2022 - 01/2019
2Infections
01/2020 - 09/2013
2Carcinoma (Carcinomatosis)
12/2019 - 06/2015
2Inflammation (Inflammations)
01/2019 - 08/2008
2Ischemia
12/2018 - 02/2008
2Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 09/2008
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2014 - 01/2008
1Anaphylaxis (Anaphylactic Shock)
01/2023
1Human Influenza (Influenza)
10/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Lymphatic Metastasis
01/2022
1Photophobia (Light Sensitivity)
01/2022
1Brain Diseases (Brain Disorder)
12/2021
1Brain Neoplasms (Brain Tumor)
11/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2021

Drug/Important Bio-Agent (IBA)

22MicroRNAs (MicroRNA)IBA
08/2022 - 01/2013
17Proteins (Proteins, Gene)FDA Link
05/2023 - 03/2004
8Doxorubicin (Adriamycin)FDA LinkGeneric
04/2023 - 01/2016
8Thymidine KinaseIBA
08/2022 - 08/2010
7PolymersIBA
08/2021 - 01/2014
6Contrast MediaIBA
01/2023 - 02/2008
6ProdrugsIBA
08/2022 - 01/2014
6Temozolomide (Temodar)FDA LinkGeneric
11/2021 - 12/2015
6EnzymesIBA
03/2020 - 01/2014
5LigandsIBA
05/2023 - 07/2008
5Biomarkers (Surrogate Marker)IBA
04/2023 - 01/2017
5tretazicarIBA
08/2022 - 01/2014
5Firefly LuciferasesIBA
01/2022 - 12/2011
5Antineoplastic Agents (Antineoplastics)IBA
08/2021 - 09/2013
4Peptides (Polypeptides)IBA
04/2023 - 03/2015
4AntioxidantsIBA
12/2022 - 06/2010
4Ganciclovir (Cytovene)FDA LinkGeneric
08/2022 - 01/2016
4LuciferasesIBA
10/2021 - 09/2012
4DNA (Deoxyribonucleic Acid)IBA
12/2019 - 07/2003
4Renilla LuciferasesIBA
08/2015 - 01/2008
3VaccinesIBA
12/2022 - 10/2020
3AntibodiesIBA
10/2022 - 02/2008
3NitroreductasesIBA
08/2022 - 01/2018
3Tumor Biomarkers (Tumor Markers)IBA
06/2022 - 01/2017
3CytokinesIBA
01/2022 - 10/2020
3SurvivinIBA
10/2021 - 11/2008
3poly(lactic-glycolic acid)-poly(ethyleneglycol) copolymerIBA
12/2020 - 03/2015
3Polylactic Acid-Polyglycolic Acid CopolymerIBA
02/2016 - 06/2015
3Estrogen ReceptorsIBA
06/2015 - 08/2010
3Hormones (Hormone)IBA
06/2015 - 07/2008
2ThymidineIBA
08/2023 - 03/2020
2Phosphotransferases (Kinase)IBA
04/2023 - 12/2013
2AntigensIBA
10/2022 - 11/2021
2GoldIBA
08/2022 - 10/2019
2Nucleic AcidsIBA
01/2022 - 03/2020
2Alkaline PhosphataseIBA
01/2022 - 04/2020
2IntegrinsIBA
10/2019 - 09/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 09/2008
2Therapeutic UsesIBA
01/2018 - 01/2014
2RRx-001IBA
01/2017 - 08/2015
2Tumor Suppressor Protein p53IBA
12/2016 - 10/2009
2Estrogens (Estrogen)FDA Link
10/2016 - 06/2015
2Orlistat (Xenical)FDA Link
02/2016 - 02/2016
2Ethylene Glycol (Monoethylene Glycol)IBA
02/2016 - 06/2015
2Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2012 - 01/2008
2Pyridinolcarbamate (P23)IBA
09/2012 - 01/2008
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008 - 02/2008
1beta-DefensinsIBA
04/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1ferric ferrocyanide (Prussian blue)FDA Link
01/2023
1Ferrosoferric Oxide (Magnetite)FDA Link
01/2023
1CyclodextrinsIBA
08/2022
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2022
1Plasminogen Activators (Plasminogen Activator)IBA
08/2022
1ChitosanIBA
08/2022
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2022
1E-SelectinIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1LipidsIBA
01/2022
1pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA
01/2022
1placental alkaline phosphataseIBA
01/2022
1Indicators and Reagents (Reagents)IBA
10/2021
1NanovaccinesIBA
08/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Vitamin EFDA LinkGeneric
01/2021

Therapy/Procedure

38Therapeutics
04/2023 - 07/2008
18Microbubbles
05/2023 - 02/2008
12Drug Therapy (Chemotherapy)
04/2023 - 02/2006
6Precision Medicine
10/2023 - 01/2014
6Immunotherapy
01/2023 - 08/2021
2Transplantation
04/2011 - 06/2010
1Lab-On-A-Chip Devices
05/2023
1Aftercare (After-Treatment)
01/2023
1Intranasal Administration
11/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2021